Search Ontology:
ChEBI
alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->3)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFoO[CH2]5C(O)NH2CH2CH2NH2-3,4-dioxocyclobutylaminomethyl group
- Term ID
- CHEBI:84691
- Synonyms
-
- 2-({2-[(6-{[N-formyl-alpha-D-perosaminyl-(1->2)-N-formyl-alpha-D-perosaminyl-(1->3)-N-formyl-alpha-D-perosaminyl-(1->2)-N-formyl-alpha-D-perosaminyl-(1->2)-N-formyl-alpha-D-perosaminyl-(1->2)-N-formyl-alpha-D-perosaminyl]oxy}hexanoyl)amino]ethyl}amino)-3,
- alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-(1->3)-alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFoO[CH2]5C(O)NH2CH2CH2NH2-3,4-dioxocyclobutylaminomethyl
- {[2-({2-[(6-{[4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl-(1->3)-4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl-(1->2)-4,6-dideoxy-4-formamido-a
- {[2-({2-[(6-{[4,6-dideoxy-4-formamido-alpha-D-mannosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannosyl-(1->3)-4,6-dideoxy-4-formamido-alpha-D-mannosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannosyl-(1->2)-4
- Definition
- An organyl group consisting of a hexasaccharide of N-formyl-alpha-D-perosamine residues linked sequentially (1->2), (1->3), (1->2), (1->2) and (1->2), and linked at the reducing end glycosidically to a 2-[2-(hexanamido)ethylamino]-3,4-dioxocyclobutylaminomethyl group used as a tether for conjugation to proteins.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->3)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFoO[CH2]5C(O)NH2CH2CH2NH2-3,4-dioxocyclobutylaminomethyl group
Phenotype where environments contain alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->3)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFoO[CH2]5C(O)NH2CH2CH2NH2-3,4-dioxocyclobutylaminomethyl group
Phenotype modified by environments containing alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->3)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFoO[CH2]5C(O)NH2CH2CH2NH2-3,4-dioxocyclobutylaminomethyl group
Human Disease Model